he pharmaceutical industry is doubling down on its campaign to force Colombia to alter its policies toward pricing and patents for medicines by enlisting the support of a congressional ally.

Over the past month, industry groups urged U.S. trade officials to place Colombia on a list of countries that purportedly fail to enforce intellectual property rights. Trade officials responded by warning Colombia that changes are needed prior to an upcoming meeting to discuss membership in the Organization for Economic Cooperation and Development, an intergovernmental trade group.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.